Glipizide

Product NDC
70518-2624
11-digit product format
705182624
Labeler code
70518
Product ID
70518-2624_d6ba7b6e-0bb5-4f5a-e053-2995a90af94c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Glipizide
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA206928
Marketing category
ANDA
Marketing start
2020-03-12
Marketing end
0000-00-00
Substance
GLIPIZIDE
Active strength
10 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2624GLIPIZIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC.]6Legacy NDC20240306_cdebc7b3-2d2f-4022-8f36-ce9a4eb27206.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-2624-07051826240030 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2624-0) 2020-03-120000-00-00NoNoCurrent
70518-2624-17051826240190 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2624-1) 2020-04-170000-00-00NoNoCurrent
70518-2624-27051826240230 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-2624-2) 2020-11-180000-00-00NoNoCurrent